Abstract
Recent studies have identified a high frequency of recurrent acquired DNA copy number abnormalities in pediatric ALL, most commonly involving genes regulating lymphoid development (
Nature
2007
;446
:758
N Engl J Med
1998
;338
:1663
Author notes
Disclosure:Research Funding: 1. Roche-sponsored gene expression profiling research unrelated to the current studies. 2. St. Jude co-owns a pending patent application with the University of Mississippi (Pub. No. 2004/0018513) drawn to leukemia gene expression profiling which has been nonexclusively licensed to Affymetrix. Membership Information: Board of Scientific Consultants for the Memorial Sloan-Kettering Cancer Center (J.R.D.). C.G.M. spoke at an Affymetrix symposium in 2007.
2007, The American Society of Hematology
2007
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal